1.Maternal and Neonatal Outcomes in Pregnant Women With Coronavirus Disease 2019 in Korea
Youseung CHUNG ; Eun Jin KIM ; Hee-Sung KIM ; Kyung-Hwa PARK ; Ji Hyeon BAEK ; Jungok KIM ; Ji Yeon LEE ; Chang-Seop LEE ; Seungjin LIM ; Shin-Woo KIM ; Eu Suk KIM ; Hye Jin SHI ; Shin Hee HONG ; Jae-Bum JUN ; Kyung-Wook HONG ; Jae-Phil CHOI ; Jinyeong KIM ; Kyung Sook YANG ; Young Kyung YOON
Journal of Korean Medical Science 2022;37(41):e297-
Background:
This study aimed to describe the maternal, obstetrical, and neonatal outcomes in pregnant women with coronavirus disease 2019 (COVID-19) and identify the predictors associated with the severity of COVID-19.
Methods:
This multicenter observational study included consecutive pregnant women admitted because of COVID-19 confirmed using reverse transcriptase-polymerase chain reaction (RT-PCR) test at 15 hospitals in the Republic of Korea between January 2020 and December 2021.
Results:
A total of 257 women with COVID-19 and 62 newborns were included in this study. Most of the patients developed this disease during the third trimester. Nine patients (7.4%) developed pregnancy-related complications. All pregnant women received inpatient treatment, of whom 9 (3.5%) required intensive care, but none of them died. The gestational age at COVID-19 diagnosis (odds ratio [OR], 1.096, 95% confidence interval [CI], 1.04–1.15) and parity (OR, 1.703, 95% CI, 1.13–2.57) were identified as significant risk factors of severe diseases. Among women who delivered, 78.5% underwent cesarean section. Preterm birth (38.5%), premature rupture of membranes (7.7%), and miscarriage (4.6%) occurred, but there was no stillbirth or neonatal death. The RT-PCR test of newborns’ amniotic fluid and umbilical cord blood samples was negative for severe acute respiratory syndrome coronavirus 2.
Conclusion
At the time of COVID-19 diagnosis, gestational age and parity of pregnant women were the risk factors of disease severity. Vertical transmission of COVID-19 was not observed, and maternal severity did not significantly affect the neonatal prognosis.
2.Usefulness of cyclic thermal therapy and red blood cell scintigraphy in patients with chemotherapy-induced peripheral neuropathy
Minjoo KIM ; Eun-Mi KIM ; Phil-Sun OH ; Seok Tae LIM ; Myung-Hee SOHN ; Eun-Kee SONG ; Keon Uk PARK ; Jin Young KIM ; Kyoung Sook WON ; Hwan-Jeong JEONG
The Korean Journal of Pain 2021;34(4):427-436
Background:
Pharmacological and non-pharmacological therapies have been used to treat patients with chemotherapy-induced peripheral neuropathy (CIPN). However, the effect of therapies in cancer patients has yet to be investigated comprehensively. We hypothesized that cyclic thermal therapy would improve blood flow and microcirculation and improve the symptoms driven by CIPN.
Methods:
The criteria of assessment were blood volume in region of interest (ROI) in the images, and European Organization for Research and Treatment of Cancer–Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20 questionnaire scores. The blood volume was quantified by using red blood cell (RBC) scintigraphy. All patients were treated 10 times during 10 days. The thermal stimulations, between 15° and 41°, were repeatedly delivered to the patient’s hands.
Results:
The total score of the questionnaires, the score of questions related to the upper limbs, the score of questions closely related to the upper limbs, and the score excluding the upper limbs questions was decreased. The blood volume was decreased, and the variance of blood volume was decreased. During cooling stimulation, the blood volume was decreased, and its variance was decreased. During warming stimulation, the blood volume was decreased, and its variance was decreased.
Conclusions
We suggest that cyclic thermal therapy is useful to alleviate CIPN symptoms by blood circulation improvement. RBC scintigraphy can provide the quantitative information on blood volume under certain conditions such as stress, as well as rest, in peripheral tissue.
3.Usefulness of cyclic thermal therapy and red blood cell scintigraphy in patients with chemotherapy-induced peripheral neuropathy
Minjoo KIM ; Eun-Mi KIM ; Phil-Sun OH ; Seok Tae LIM ; Myung-Hee SOHN ; Eun-Kee SONG ; Keon Uk PARK ; Jin Young KIM ; Kyoung Sook WON ; Hwan-Jeong JEONG
The Korean Journal of Pain 2021;34(4):427-436
Background:
Pharmacological and non-pharmacological therapies have been used to treat patients with chemotherapy-induced peripheral neuropathy (CIPN). However, the effect of therapies in cancer patients has yet to be investigated comprehensively. We hypothesized that cyclic thermal therapy would improve blood flow and microcirculation and improve the symptoms driven by CIPN.
Methods:
The criteria of assessment were blood volume in region of interest (ROI) in the images, and European Organization for Research and Treatment of Cancer–Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20 questionnaire scores. The blood volume was quantified by using red blood cell (RBC) scintigraphy. All patients were treated 10 times during 10 days. The thermal stimulations, between 15° and 41°, were repeatedly delivered to the patient’s hands.
Results:
The total score of the questionnaires, the score of questions related to the upper limbs, the score of questions closely related to the upper limbs, and the score excluding the upper limbs questions was decreased. The blood volume was decreased, and the variance of blood volume was decreased. During cooling stimulation, the blood volume was decreased, and its variance was decreased. During warming stimulation, the blood volume was decreased, and its variance was decreased.
Conclusions
We suggest that cyclic thermal therapy is useful to alleviate CIPN symptoms by blood circulation improvement. RBC scintigraphy can provide the quantitative information on blood volume under certain conditions such as stress, as well as rest, in peripheral tissue.
4.Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome.
Wan Beom PARK ; Kang Il JUN ; Gayeon KIM ; Jae Phil CHOI ; Ji Young RHEE ; Shinhyea CHEON ; Chang Hyun LEE ; Jun Sun PARK ; Yeonjae KIM ; Joon Sung JOH ; Bum Sik CHIN ; Pyeong Gyun CHOE ; Ji Hwan BANG ; Sang Won PARK ; Nam Joong KIM ; Dong Gyun LIM ; Yeon Sook KIM ; Myoung don OH ; Hyoung Shik SHIN
Journal of Korean Medical Science 2018;33(24):e169-
This nationwide, prospective cohort study evaluated pulmonary function and radiological sequelae according to infection severity in 73 survivors from the 2015 Middle East respiratory syndrome (MERS) outbreak in Korea. Patients with severe pneumonia in MERS-coronavirus infection had more impaired pulmonary function than those with no or mild pneumonia at the 1-year follow-up, which was compatible with the radiological sequelae. Severe pneumonia significantly impairs pulmonary function and makes long radiological sequelae in MERS.
Cohort Studies
;
Coronavirus
;
Coronavirus Infections*
;
Follow-Up Studies
;
Humans
;
Korea
;
Middle East*
;
Pneumonia*
;
Prospective Studies
;
Survivors
5.Neurological Complications during Treatment of Middle East Respiratory Syndrome.
Jee Eun KIM ; Jae Hyeok HEO ; Hye ok KIM ; Sook hee SONG ; Sang Soon PARK ; Tai Hwan PARK ; Jin Young AHN ; Min Ky KIM ; Jae Phil CHOI
Journal of Clinical Neurology 2017;13(3):227-233
BACKGROUND AND PURPOSE: Middle East respiratory syndrome (MERS) has a high mortality rate and pandemic potential. However, the neurological manifestations of MERS have rarely been reported since it first emerged in 2012. METHODS: We evaluated four patients with laboratory-confirmed MERS coronavirus (CoV) infections who showed neurological complications during MERS treatment. These 4 patients were from a cohort of 23 patients who were treated at a single designated hospital during the 2015 outbreak in the Republic of Korea. The clinical presentations, laboratory findings, and prognoses are described. RESULTS: Four of the 23 admitted MERS patients reported neurological symptoms during or after MERS-CoV treatment. The potential diagnoses in these four cases included Bickerstaff's encephalitis overlapping with Guillain-Barré syndrome, intensive-care-unit-acquired weakness, or other toxic or infectious neuropathies. Neurological complications did not appear concomitantly with respiratory symptoms, instead being delayed by 2–3 weeks. CONCLUSIONS: Neuromuscular complications are not rare during MERS treatment, and they may have previously been underdiagnosed. Understanding the neurological manifestations is important in an infectious disease such as MERS, because these symptoms are rarely evaluated thoroughly during treatment, and they may interfere with the prognosis or require treatment modification.
Cohort Studies
;
Communicable Diseases
;
Coronavirus
;
Coronavirus Infections*
;
Diagnosis
;
Encephalitis
;
Guillain-Barre Syndrome
;
Humans
;
Middle East Respiratory Syndrome Coronavirus
;
Middle East*
;
Mortality
;
Neurologic Manifestations
;
Pandemics
;
Peripheral Nervous System Diseases
;
Prognosis
;
Republic of Korea
6.Epidemiologic Characteristics of Intentional Poisoning: Emergency Department Based Injury in-depth Surveillance During 2011–2015.
Hak Soo LEE ; Juhee HAN ; Ji Hoon KIM ; Sunpyo KIM ; Sun Hyu KIM ; Ji Sook LEE ; Gyu Chong CHO ; Chul HAN ; Joon Min PARK ; Sung Phil CHUNG ; Min Joung KIM
Journal of The Korean Society of Clinical Toxicology 2017;15(2):131-139
PURPOSE: The purpose of this study was to investigate the epidemiologic characteristics of patients who visited emergency departments (EDs) after intentional poisoning in Korea. METHODS: This study retrospectively analyzed the data of of 23 hospitals during a five-year period, between 2011 and 2015. We included patients who inflicted injury to themselves - attempt of suicide - by means of poisoning. RESULTS: A total of 18,121 patients visited an ED after intentional poisoning. Among them, 58.3% were females; however, there were more males among those aged 60 years or older. The mortality rate for males was 8.6%, which was 3.1 times higher than that for females with 2.8%. The most common poison was pesticides (35.4%) in males and sedative-hypnotics (44.0%) in females. The most common causative agent of death was pesticide in both sexes (75.2% and 65.3%, respectively). Since the production of paraquat was discontinued in 2011, the number of deaths from pesticide poisoning has decreased. The mortality rate declined in both males and females, from 12.6% and 4.5% in 2011 to 7.1% and 2.1% in 2015, respectively. CONCLUSION: In this study, we analyzed the epidemiologic characteristics of intentional poisoning, especially the frequency of suicide attempts by gender and age group, the cause of suicide, and the causative agent. This can be used as basic data for establishing policies to reduce and prevent suicide attempts by poisoning.
Emergencies*
;
Emergency Service, Hospital*
;
Epidemiology
;
Female
;
Humans
;
Korea
;
Male
;
Mortality
;
Paraquat
;
Pesticides
;
Poisoning*
;
Retrospective Studies
;
Suicide
7.Erratum to: The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group.
Do Young KWON ; Seong Beom KOH ; Jae Hyeok LEE ; Hee Kyung PARK ; Han Joon KIM ; Hae Won SHIN ; Jinyoung YOUN ; Kun Woo PARK ; Sun Ah CHOI ; Sang Jin KIM ; Seong Min CHOI ; Ji Yun PARK ; Beom S. JEON ; Ji Young KIM ; Sun Ju CHUNG ; Chong Sik LEE ; Jeong Ho PARK ; Tae Beom AHN ; Won Chan KIM ; Hyun Sook KIM ; Sang Myung CHEON ; Hee Tae KIM ; Jee Young LEE ; Ji Sun KIM ; Eun Joo KIM ; Jong Min KIM ; Kwang Soo LEE ; Joong Seok KIM ; Min Jeong KIM ; Jong Sam BAIK ; Ki Jong PARK ; Hee Jin KIM ; Mee Young PARK ; Ji Hoon KANG ; Sook Kun SONG ; Yong Duk KIM ; Ji Young YUN ; Ho Won LEE ; Hyung Geun OH ; Jinwhan CHO ; In Uk SONG ; Young H. SOHN ; Phil Hyu LEE ; Jae Woo KIM
Journal of Clinical Neurology 2017;13(3):315-315
The original version of this article contained wrong informations of some authors which should be changed.
8.The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group.
Do Young KWON ; Seong Beom KOH ; Jae Hyeok LEE ; Hee Kyung PARK ; Han Joon KIM ; Hae Won SHIN ; Jinyoung YOUN ; Kun Woo PARK ; Sun Ah CHOI ; Sang Jin KIM ; Seong Min CHOI ; Ji Yun PARK ; Beom S JEON ; Ji Young KIM ; Sun Ju CHUNG ; Chong Sik LEE ; Jeong Ho PARK ; Tae Beom AHN ; Won Chan KIM ; Hyun Sook KIM ; Sang Myung CHEON ; Hee Tae KIM ; Jee Young LEE ; Ji Sun KIM ; Eun Joo KIM ; Jong Min KIM ; Kwang Soo LEE ; Joong Seok KIM ; Min Jeong KIM ; Jong Sam BAIK ; Ki Jong PARK ; Hee Jin KIM ; Mee Young PARK ; Ji Hoon KANG ; Sook Kun SONG ; Yong Duk KIM ; Ji Young YUN ; Ho Won LEE ; Hyung Geun OH ; Jinwhan CHO ; In Uk SONG ; Young H SOHN ; Phil Hyu LEE ; Jae Woo KIM
Journal of Clinical Neurology 2016;12(4):393-402
BACKGROUND AND PURPOSE: Nonmotor symptoms (NMS) in Parkinson's disease (PD) have multisystem origins with heterogeneous manifestations that develop throughout the course of PD. NMS are increasingly recognized as having a significant impact on the health-related quality of life (HrQoL). We aimed to determine the NMS presentation according to PD status, and the associations of NMS with other clinical variables and the HrQoL of Korean PD patients. METHODS: We surveyed patients in 37 movement-disorders clinics throughout Korea. In total, 323 PD patients were recruited for assessment of disease severity and duration, NMS, HrQoL, and other clinical variables including demographics, cognition, sleep scale, fatigability, and symptoms. RESULTS: In total, 98.1% of enrolled PD subjects suffered from various kinds of NMS. The prevalence of NMS and scores in each NMS domain were significantly higher in the PD group, and the NMS worsened as the disease progressed. Among clinical variables, disease duration and depressive mood showed significant correlations with all NMS domains (p<0.001). NMS status impacted HrQoL in PD (rS=0.329, p<0.01), and the association patterns differed with the disease stage. CONCLUSIONS: The results of our survey suggest that NMS in PD are not simply isolated symptoms of degenerative disease, but rather exert significant influences throughout the disease course. A novel clinical approach focused on NMS to develop tailored management strategies is warranted to improve the HrQoL in PD patients.
Cognition
;
Demography
;
Humans
;
Korea
;
Movement Disorders*
;
Parkinson Disease*
;
Prevalence
;
Quality of Life*
9.Part 6. Pediatric advanced life support: 2015 Korean Guidelines for Cardiopulmonary Resuscitation.
Do Kyun KIM ; Won Kyoung JHANG ; Ji Yun AHN ; Ji Sook LEE ; Yoon Hee KIM ; Bongjin LEE ; Gi Beom KIM ; Jin Tae KIM ; June HUH ; June Dong PARK ; Sung Phil CHUNG ; Sung Oh HWANG
Clinical and Experimental Emergency Medicine 2016;3(Suppl 1):S48-S61
No abstract available.
Cardiopulmonary Resuscitation*
10.Part 5. Pediatric basic life support: 2015 Korean Guidelines for Cardiopulmonary Resuscitation.
Ji Sook LEE ; Ji Yun AHN ; Do Kyun KIM ; Yoon Hee KIM ; Bongjin LEE ; Won Kyoung JHANG ; Gi Beom KIM ; Jin Tae KIM ; June HUH ; June Dong PARK ; Sung Phil CHUNG ; Sung Oh HWANG
Clinical and Experimental Emergency Medicine 2016;3(Suppl 1):S39-S47
No abstract available.
Cardiopulmonary Resuscitation*

Result Analysis
Print
Save
E-mail